MPDL3280A Treatment in Patients With Locally Advance or Metastatic Non-small Cell Lung, Cancer of the Urinary Tract and Triple Negative Breast Cancer After or During Investigational Imaging
Phase of Trial: Phase II
Latest Information Update: 22 Jun 2018
At a glance
- Drugs Atezolizumab (Primary)
- Indications Advanced breast cancer; Bladder cancer; Non-small cell lung cancer; Solid tumours
- Focus Therapeutic Use
- 13 Jun 2018 Planned number of patients changed from 40 to 79.
- 13 Jun 2018 Planned End Date changed from 1 Sep 2019 to 1 Dec 2020.
- 13 Jun 2018 Planned primary completion date changed from 1 Sep 2019 to 1 Dec 2020.